The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation
View ORCID ProfileFrank Sandmann, View ORCID ProfileNicholas G. Davies, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, View ORCID ProfileAnna Vassall, View ORCID ProfileW John Edmunds, View ORCID ProfileMark Jit
doi: https://doi.org/10.1101/2020.09.24.20200857
Frank Sandmann
1London School of Hygiene and Tropical Medicine, London, UK
2Statistics, Modelling and Economics Department, National Infection Service, Public Health England, London, UK
Nicholas G. Davies
1London School of Hygiene and Tropical Medicine, London, UK
Anna Vassall
1London School of Hygiene and Tropical Medicine, London, UK
W John Edmunds
1London School of Hygiene and Tropical Medicine, London, UK
Mark Jit
1London School of Hygiene and Tropical Medicine, London, UK
3School of Public Health, University of Hong Kong, Hong Kong SAR, China
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted September 25, 2020.
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation
Frank Sandmann, Nicholas G. Davies, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, Anna Vassall, W John Edmunds, Mark Jit
medRxiv 2020.09.24.20200857; doi: https://doi.org/10.1101/2020.09.24.20200857
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation
Frank Sandmann, Nicholas G. Davies, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, Anna Vassall, W John Edmunds, Mark Jit
medRxiv 2020.09.24.20200857; doi: https://doi.org/10.1101/2020.09.24.20200857
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12859)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4663)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2963)
- Health Policy (1078)
- Hematology (394)
- HIV/AIDS (940)
- Medical Education (431)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4447)
- Nursing (239)
- Nutrition (653)
- Oncology (2313)
- Ophthalmology (657)
- Orthopedics (260)
- Otolaryngology (329)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7043)
- Radiology and Imaging (1561)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (388)
- Surgery (495)
- Toxicology (60)
- Transplantation (213)
- Urology (186)